Tag:
Orchid Chemicals
Latest Headlines
Latest Headlines
Orchid to pay debt after $400M injectables deal
Orchid Chemicals & Pharmaceuticals isn't so different from the average American with lots of credit card debt. A big chunk of its income is earmarked to pay bills. The Indian drugmaker says it
Orchid in development deal with Merck
India's Orchid Chemicals and Pharmaceuticals says it has struck a development deal with Merck for the discovery anti-infective drugs. That pact has the potential to earn more than $100 million for
Diakron in-licenses program, finds partner
Diakron Pharmaceuticals has simultaneously struck a pair of deals to in-license a Phase I oral anti-coagulant therapy from Merck while signing India's Orchid Chemicals as a development partner for
Could Clarinex be vulnerable to generics?
Consider this scenario from Fred Hassan's  nightmares: The $800 million Clarinex, ostensibly under patent till 2020,
